Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Shattock

Showing results (81-90 of 210) with videos related to

Pageof 21
Sort By:
ACS Nano|May 4, 2019
The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin ExplantsAnna K Blakney, Paul F McKay, Bárbara Ibarzo Yus, et al.
Plos One|January 22, 2011
A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environmentFrank Wegmann, George Krashias, Kerstin Lühn, et al.
AIDS (London, England)|June 8, 2021
The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidateCarolina Herrera, Sarah Harman, Yoann Aldon, et al.
Molecular Therapy. Nucleic Acids|January 6, 2025
A sort and sequence approach to dissect heterogeneity of response to a self-amplifying RNA vector in a novel human muscle cell lineRachel D Barton, John S Tregoning, Ziyin Wang, et al.
Journal of Virology|April 25, 2008
Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine modelPedro M M Mesquita, Sarah S Wilson, Philippe Manlow, et al.
Frontiers in Immunology|March 15, 2018
Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in HumansJenna Anderson, Thorunn A Olafsdottir, Sven Kratochvil, et al.
Biology Methods & Protocols|March 14, 2023
Biophysical characterization of the structure of a SARS-CoV-2 self-amplifying RNA (saRNA) vaccineDaniel P Myatt, Lewis Wharram, Charlotte Graham, et al.
Vaccine|May 11, 2011
Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responsesChristelle Liard, Séverine Munier, Mauricio Arias, et al.
AIDS (London, England)|June 5, 2007
HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1Jean-Charles Grivel, Julie Elliott, Andrea Lisco, et al.
Plos One|December 14, 2012
HIV-1 expressing the envelopes of transmitted/founder or control/reference viruses have similar infection patterns of CD4 T-cells in human cervical tissue ex vivoMelanie Merbah, Anush Arakelyan, Tara Edmonds, et al.
Pageof 21

Showing results (81-90 of 210) with videos related to

Sort By:
Pageof 21
ACS Nano|May 4, 2019
The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin ExplantsAnna K Blakney, Paul F McKay, Bárbara Ibarzo Yus, et al.
Plos One|January 22, 2011
A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environmentFrank Wegmann, George Krashias, Kerstin Lühn, et al.
AIDS (London, England)|June 8, 2021
The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidateCarolina Herrera, Sarah Harman, Yoann Aldon, et al.
Molecular Therapy. Nucleic Acids|January 6, 2025
A sort and sequence approach to dissect heterogeneity of response to a self-amplifying RNA vector in a novel human muscle cell lineRachel D Barton, John S Tregoning, Ziyin Wang, et al.
Journal of Virology|April 25, 2008
Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine modelPedro M M Mesquita, Sarah S Wilson, Philippe Manlow, et al.
Frontiers in Immunology|March 15, 2018
Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in HumansJenna Anderson, Thorunn A Olafsdottir, Sven Kratochvil, et al.
Biology Methods & Protocols|March 14, 2023
Biophysical characterization of the structure of a SARS-CoV-2 self-amplifying RNA (saRNA) vaccineDaniel P Myatt, Lewis Wharram, Charlotte Graham, et al.
Vaccine|May 11, 2011
Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responsesChristelle Liard, Séverine Munier, Mauricio Arias, et al.
AIDS (London, England)|June 5, 2007
HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1Jean-Charles Grivel, Julie Elliott, Andrea Lisco, et al.
Plos One|December 14, 2012
HIV-1 expressing the envelopes of transmitted/founder or control/reference viruses have similar infection patterns of CD4 T-cells in human cervical tissue ex vivoMelanie Merbah, Anush Arakelyan, Tara Edmonds, et al.
Pageof 21